Recent Patents on Therapeutic Agents for Cancer
- Authors: Xun Li, Yalin Li, Wenfang Xu3
-
View Affiliations Hide Affiliations3 Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Ji'nan 250012, Shandong Province, P.R. China, China
- Source: Frontiers in Anti-Cancer Drug Discovery: Volume 1 , pp 623-740
- Publication Date: December 2010
- Language: English
Preview this chapter:
Recent Patents on Therapeutic Agents for Cancer, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9781608051618/chapter-28-1.gif
Cancer is one of the most dreaded diseases with a complex pathogenesis, which threats human life greatly. Multidisciplinary scientific investigations are making best efforts to combat this disease and put to the identification of novel anticancer agents. Patent anticancer agents registered in China are therefore increasing dramatically during the past ten years, which will be reviewed briefly in this article. I. Platinum complexes II. Anthracycline analogs (including doxorubicin derivatives) III. Quinoline analogs IV. Podophyllotoxins analogs V. Taxane analogs
Hardbound ISBN:
9781608056262
Ebook ISBN:
9781608051618
-
From This Site
/content/books/9781608051618.chapter-28dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
/content/books/9781608051618.chapter-28
dcterms_subject,pub_keyword
-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData
10
5
Chapter
content/books/9781608051618
Book
false
en
